nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A pharmacokinetic model for amiodarone in infants developed from an opportunistic sampling trial and published literature data
|
Dallefeld, Samantha H. |
|
2018 |
45 |
3 |
p. 419-430 |
artikel |
2 |
Assessing QT/QTc interval prolongation with concentration-QT modeling for Phase I studies: impact of computational platforms, model structures and confidence interval calculation methods
|
Lu, Jingtao |
|
2018 |
45 |
3 |
p. 469-482 |
artikel |
3 |
A tutorial on model informed approaches to cardiovascular safety with focus on cardiac repolarisation
|
Cheung, S. Y. A. |
|
2018 |
45 |
3 |
p. 365-381 |
artikel |
4 |
Correction to: Scientific white paper on concentration-QTc modeling
|
Garnett, Christine |
|
2018 |
45 |
3 |
p. 399 |
artikel |
5 |
Drug–physiology interaction and its influence on the QT prolongation-mechanistic modeling study
|
Wiśniowska, Barbara |
|
2018 |
45 |
3 |
p. 483-490 |
artikel |
6 |
Editorial to themed issue: Recent advances in cardiovascular pharmacokinetic–pharmacodynamic modeling and simulation
|
Bonate, Peter |
|
2018 |
45 |
3 |
p. 353 |
artikel |
7 |
Guiding dose adjustment of amlodipine after co-administration with ritonavir containing regimens using a physiologically-based pharmacokinetic/pharmacodynamic model
|
Mukherjee, Dwaipayan |
|
2018 |
45 |
3 |
p. 443-456 |
artikel |
8 |
Importance of QT/RR hysteresis correction in studies of drug-induced QTc interval changes
|
Malik, Marek |
|
2018 |
45 |
3 |
p. 491-503 |
artikel |
9 |
Leveraging model-informed approaches for drug discovery and development in the cardiovascular space
|
Dockendorf, Marissa F. |
|
2018 |
45 |
3 |
p. 355-364 |
artikel |
10 |
Pharmacodynamic modeling of cardiac biomarkers in breast cancer patients treated with anthracycline and trastuzumab regimens
|
Vries Schultink, Aurelia H. M. de |
|
2018 |
45 |
3 |
p. 431-442 |
artikel |
11 |
Population pharmacokinetics and exposure–response modeling and simulation for evolocumab in healthy volunteers and patients with hypercholesterolemia
|
Kuchimanchi, Mita |
|
2018 |
45 |
3 |
p. 505-522 |
artikel |
12 |
Quantitative approach for cardiac risk assessment and interpretation in tuberculosis drug development
|
Polak, Sebastian |
|
2018 |
45 |
3 |
p. 457-467 |
artikel |
13 |
Scientific white paper on concentration-QTc modeling
|
Garnett, Christine |
|
2017 |
45 |
3 |
p. 383-397 |
artikel |
14 |
Systems pharmacological analysis of mitochondrial cardiotoxicity induced by selected tyrosine kinase inhibitors
|
Vaidya, Tanaya |
|
2018 |
45 |
3 |
p. 401-418 |
artikel |